TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN’S DISEASE: SYSTEMATIC REVIEW
Authors:
- Luana BernardiLBLuana Bernardi
- Carlos Henrique Marques dos SantosCSCarlos Henrique Marques dos Santos
- Verônica Assalin Zorgetto PinheiroVerônica Assalin Zorgetto Pinheiro
- Rodrigo Juliano OliveiraRORodrigo Juliano Oliveira
- Andreia Conceição Milan Brochado Antoniolli-SilvaAAAndreia Conceição Milan Brochado Antoniolli-Silva
Open Access
- 1 January 2019
- journal article
- review article
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 32 (4) , e1465
Abstract
Background: Crohn’s disease is a pathological condition that has different options of treatment, but there are patients who need other therapeutic approach, such as the use of adipose-derived mesenchymal stem cells. Aim: Systematic literature review to determine the different ways of adipose-derived mesenchymal stem cells administration in humans with luminal refractory and perianal fistulizing Crohn’s disease. Methods: It was conducted a search for articles (from 2008 to 2018) on PubMed and ScienceDirect databases using the keywords Crohn’s disease, fistulizing Crohn’s disease, luminal Crohn’s disease and transplantation of mesenchymal stem cells or mesenchymal stem cells or stromal cells. Thirteen publications were selected for analysis. Results: Only one study referred to the luminal Crohn´s disease. The number of cells administered was variable, occurring mainly through subcutaneous adipose tissue by liposuction. It could be highlighted the autologous transplant with exclusive infusion of mesenchymal stem cells. The procedures involved in pre-transplant were mainly curettage, setons placement and stitching with absorbable suture, and conducting tests and drug treatment for luminal Crohn´s disease. During transplant, the injection of mesenchymal stem cells across the fistula path during the transplant was mainly on the intestinal tract wall. Conclusion: Although the use of mesenchymal stem cells is promising, the transplant on the luminal region should be more investigated. The injection of mesenchymal stem cells, exclusively, is more explored when compared to treatment with other products. The preparation of the fistulizing tract and the location of cell transplantation involve standardized health care in most studies.Keywords
This publication has 30 references indexed in Scilit:
- Modern management of perianal fistulas in Crohn’s disease: future directionsGut, 2018
- First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn’s diseaseStem Cell Research & Therapy, 2018
- Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1Oncogene, 2017
- Mesenchymal Stem Cell Therapy for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2015
- Long-Term Results of Adipose-Derived Stem Cell Therapy for the Treatment of Crohn's FistulaStem Cells Translational Medicine, 2015
- Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpointsCytotherapy, 2013
- Autologous Adipose Tissue-Derived Stem Cells for the Treatment of Crohn's Fistula: A Phase I Clinical StudyCell Transplantation, 2013
- Crohn's diseaseThe Lancet, 2012
- Autologous Expanded Adipose-Derived Stem Cells for the Treatment of Complex Cryptoglandular Perianal FistulasDiseases of the Colon & Rectum, 2012
- FIBRIN CONTAINING GELS INDUCE ANGIOGENESIS - IMPLICATIONS FOR TUMOR STROMA GENERATION AND WOUND-HEALING1987